Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (33172)	12/15/2009 1:49:23 AM
From: Brander	Read Replies (1) \| Respond to of 52153

Let's hope they don't hype the market and make some guys think they are abnormal when there is really nothing wrong with them. The problem with conditions like P.E. is there is a wide range of normal response, no defining line between normal and abnormal, and it is emotionally loaded. So, it is relatively easy for marketers to convince some people they have a problem that needs medical attention, when really they don't. Like some of those commercials for depression: "Do you ever feel sad or blue?, Do you wish you had more energy? If so, you might have depression and should ask your doctor about our antidepressant." Almost everybody could answer yes to these questions, but only a small percentage of them are medically depressed. The P.E. drug J&J has up for approval(Priligy) is a spray on combination of two common, generic local anesthetics (lidocaine and prilocaine)--the same thing you get in the dentists office. I think it would be easy to compound them. Also, there have been OTC creams available for some time that do the same thing--numb 'the unit'.